RICB specializes in the development and manufacture of modern high-tech medical devices, in particular detection devices using the latest technologies for the modification of silicon nanosurfaces. Our AIMEE detection system is based on silicon-modified FET transistors modified with specific antibodies to blood proteins. Our team of developers has worked on the product from its design to the final implementation and is still working on new improvements of this detection system.
RICB offers broad-spectrum services: the development and research of recombinant proteins, the modification of nanosurfaces, the design and implementation of electronic high-tech equipment, especially for use in medicine and life science, as well as the work of other biotechnological and biomechatronic processes.
In RICB, our team also deals with the production and optimization of recombinant protein production, including cell line preparation, separation and purification of the resulting proteins, focusing on the highest yield, purity and quality of the obtained product.